PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT

摘要

The present invention relates to a pharmaceutical composition for preventing or treating myositis and, more specifically, to a pharmaceutical composition for preventing or treating myositis, comprising mitochondria as an active ingredient. When administered to an entity suffering from myositis, the pharmaceutical composition comprising foreign mitochondria as an active ingredient, according to the present invention, can reduce infiltrative inflammatory cells among myocytes of the entity. Also, the pharmaceutical composition according to the present invention effectively suppresses the expression of IL-1β, TNF-α, and IL-6, which are inflammatory cytokines. Accordingly, the pharmaceutical composition according to the present invention can be beneficially used in the prevention or treatment of myositis.